Home > News > Nano silicon boosts tumour fight
June 18th, 2004
Nano silicon boosts tumour fight
The tiny science of nanotechnology could give a big boost to cancer patients undergoing tumour treatments. BrachySil, by biotech firm pSivida, is a silicon-based nanoscale system that takes drugs direct to the tumour site. Silicon's structure carries an electrical current, is porous and adaptable. This means the right amount of drug can be released when needed.
Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014
More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014
High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014